Targeted delivery of flagellin by nebulization offers optimized respiratory immunity and defense against pneumococcal pneumonia
M. Baldry, C. Costa, Y. Zeroual, D. Cayet, J. Pardessus, D. Soulard, F. Wallet, D. Beury, D. Hot, R. MacLoughlin, N. Heuze-Vourc'h, C. Carnoy, J.-C. Sirard
This study evaluates nebulized flagellin as a therapeutic for antibiotic-resistant pneumococcal pneumonia, showing it enhances immune response and synergizes with amoxicillin in mice.
bioRxiv · Jun 17, 2024Microbiology